Long-term Debt and Lease Obligation of AYTU BIOPHARMA, INC from 30 Jun 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of long-term debt and lease obligation, classified as noncurrent.
Summary
AYTU BIOPHARMA, INC quarterly Long-term Debt and Lease Obligation in USD history and change rate from 30 Jun 2020 to 31 Dec 2025.
  • AYTU BIOPHARMA, INC Long-term Debt and Lease Obligation for the quarter ending 31 Dec 2025 was $9,998,000, a 0.15% increase year-over-year.
Source SEC data
View on sec.gov
Long-term Debt and Lease Obligation, Quarterly (USD)
Long-term Debt and Lease Obligation, YoY Quarterly Change (%)

AYTU BIOPHARMA, INC Quarterly Long-term Debt and Lease Obligation (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $9,998,000 +$15,000 +0.15% 31 Dec 2025 10-Q 03 Feb 2026 2026 Q2
Q3 2025 $10,447,000 +$17,000 +0.16% 30 Sep 2025 10-Q 13 Nov 2025 2026 Q1
Q2 2025 $10,895,000 +$18,000 +0.16% 30 Jun 2025 10-Q 03 Feb 2026 2026 Q2
Q1 2025 $9,535,000 +$9,535,000 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $9,983,000 -$4,995,000 -33% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q2
Q3 2024 $10,430,000 -$4,412,000 -30% 30 Sep 2024 10-Q 13 Nov 2024 2025 Q1
Q2 2024 $10,877,000 -$3,836,000 -26% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $0 -$11,386,000 -100% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 $14,978,000 +$445,000 +3.1% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $14,842,000 +$1,282,000 +9.5% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $14,713,000 +$434,000 +3% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q1 2023 $11,386,000 -$2,781,000 -20% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 $14,533,000 +$14,404,000 +11166% 31 Dec 2022 10-Q 21 Feb 2023 2023 Q2
Q3 2022 $13,560,000 +$13,406,000 +8705% 30 Sep 2022 10-Q/A 21 Feb 2023 2023 Q1
Q2 2022 $14,279,000 +$14,099,000 +7833% 30 Jun 2022 10-K 12 Oct 2023 2023 FY
Q1 2022 $14,167,000 31 Mar 2022 10-Q 16 May 2022 2022 Q3
Q4 2021 $129,000 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $154,000 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q2 2021 $180,000 +$180,000 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q2 2020 $0 30 Jun 2020 10-K 28 Sep 2021 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.